Abel Hall, LLC Merck & Co., Inc. Transaction History
Abel Hall, LLC
- $248 Billion
- Q3 2025
A detailed history of Abel Hall, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Abel Hall, LLC holds 10,423 shares of MRK stock, worth $967,879. This represents 0.35% of its overall portfolio holdings.
Number of Shares
10,423
Previous 10,470
0.45%
Holding current value
$967,879
Previous $829 Million
5.55%
% of portfolio
0.35%
Previous 0.38%
Shares
8 transactions
Others Institutions Holding MRK
# of Institutions
3,881Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...